Developer docs
API playgroundTry for free, no card

Search company profiles

Molecular Designs

Full company profile

uuid0005dvh

Namestring
Molecular Designs
Legal namestring
Molecular Designs, LLC
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Molecular Designs is a physician-founded molecular diagnostics and life science research tools company headquartered in Birmingham, Alabama. The company operates two divisions: a clinical diagnostics business built around the Simplicity™ platform (pre-plated breakaway multiplex PCR panels, the Simplicity Dx automated magnetic bead extraction system, Nest nylon flocked collection swabs with Inactivation Transport Medium, Opti-Swab transport systems, and the Simplicity Connect cloud-based LIS/CRM) and a life science research products division acquired through Lamda Biotech in September 2024, which sells PCR reagents, qPCR/RT-PCR reagents, direct PCR genotyping kits, protein research tools, DNA/RNA purification kits, DNA ladders, SafeStain, culture media, and a plasmid DNA prep service via research.moleculardesigns.com.

The underlying technology combines proprietary PCR chemistry, magnetic bead-based nucleic acid extraction (>98% recovery consistency, 30-minute runs on 1-32 samples), and integrated cloud software that connects to EHR, billing, and PCR instruments from ThermoFisher QuantStudio 5 Dx, BioFire FilmArray, BD MAX, and Sensititre ARIS. Manufacturing occurs in a 7,000 sq. ft. ISO 7 clean room facility with six high-speed Tecan filler machines producing 1,500-5,000 PCR plates per day, all under ISO 13485:2016 and GMP quality systems. R&D includes 10 PhDs on staff and 21 patents.

Molecular Designs monetizes through one-time sales of clinical PCR panels, extraction instruments, and consumables; subscription/quote-based licensing of Simplicity Connect; and unit-priced e-commerce sales of life science research reagents. Clinical products are sold via direct enterprise sales, while research products are sold direct-to-customer online with academic and volume pricing programs. Customers include clinical and reference laboratories performing infectious disease testing and academic/biopharma research laboratories purchasing PCR reagents and consumables.

Short descriptiontext

Molecular Designs is a physician-founded molecular diagnostics company that sells pre-plated multiplex PCR panels, automated extraction systems, specimen collection kits, and a cloud LIS/CRM to clinical/reference laboratories, plus research-grade PCR reagents and consumables to academic and biopharma labs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBirmingham, United States
HQ citystring
Birmingham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics, PCR products, nucleic acid extraction, multiplex PCR panels, clinical diagnostics
Industry4 codes
1Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
CodeHLAHAAADPrimaryYes
2Molecular & Genetic Testing (PCR/NGS/qPCR)
CodeHLAGADAFPrimaryNo
3Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
CodeHLAGAIAFPrimaryNo
4Molecular Diagnostics (PCR/qPCR, NGS-based assays)
CodeHLAAALAAPrimaryNo
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
  • Medical Laboratories621511
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
  • Services-Medical Laboratories8071
Product category
Molecular Diagnostics / PCR-based Clinical Diagnostics
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1PCR Products and Consumables
TypeOne Time License
Description

Molecular Designs generates revenue through the sale of PCR products including Simplicity Panels (pre-plated PCR assays), extraction systems, collection kits, and related consumables. The company operates both a clinical diagnostics division (moleculardesigns.com) and a life science research products division (research.moleculardesigns.com).

moleculardesigns.com
2Simplicity Connect LIS Software
TypeSubscription Recurring
Description

Cloud-based laboratory information system offered with flexible licensing and pricing model that scales with customer needs. Includes portals for clinicians, technicians, and customer support.

moleculardesigns.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Technology or R&D, Supply Chain
Pricing details3 tiers
1Individual Research Products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products available at individual unit prices starting from approximately $50 (GoGreen Taq Plus Master Mix) to over $1,000 (agarose, combo packs). Prices displayed include 1KB Plus DNA Ladder at $558, Taq Plus 2X PCR MasterMix 25ml at $600, qPCR MasterMix at $284.

moleculardesigns.com
2Academic and Volume Pricing Programs
ModelUnit PricingBilling cadenceMulti-year contract
Notes

Special pricing programs available for academic institutions and volume purchases. Contact sales for specific pricing.

moleculardesigns.com
3Simplicity Connect LIS
ModelSubscriptionBilling cadenceAnnual
Notes

Flexible licensing model that scales as labs grow. All clinician, technician, and customer portals included. Quote-based pricing.

moleculardesigns.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Molecular Designs develops, manufactures, and sells PCR-based molecular diagnostic products and life science research reagents under the Simplicity™ platform. Its clinical portfolio includes pre-plated multiplex PCR panels, an automated magnetic bead nucleic acid extraction system, specimen collection/transport products, and a cloud-based LIS/CRM. Through its Life Science Products division (acquired from Lamda Biotech in 2024), it also sells PCR reagents, qPCR reagents, DNA/RNA purification kits, and protein research consumables to research laboratories.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 82% less prep time with streamlined workflows
+6 more records
Product overview1 text field

Molecular Designs operates as a physician-founded molecular technology company offering a unified product portfolio centered on Simplicity™ branded clinical diagnostic solutions and a separate Life Science Products division. The clinical portfolio consists of Simplicity Panels (customizable multiplex PCR plates), Simplicity Dx Extraction System (automated magnetic bead-based nucleic acid extraction), Nest Collection (nylon flocked swabs with ITM), Opti-Swab Transport System, and Simplicity Connect (cloud-based LIS/CRM platform). The company also offers an IVD respiratory panel for COVID/Flu/RSV in development. Through the 2024 acquisition of Lamda Biotech, Molecular Designs expanded into Life Science Products for research laboratories, including PCR reagents, qPCR/RT-PCR reagents, Direct PCR genotyping kits, protein research tools, DNA/RNA purification products, DNA ladders, SafeStain, culture media, and plasmid DNA preparation services. All Simplicity clinical products are manufactured under GMP and ISO 13485:2016 quality standards for research use only (RUO), with IVD products in development.

Product and service15 records
1Simplicity Panel™
CategoryMultiplex PCR Assay Panels
Description

Customizable multiplex PCR plates that identify multiple pathogens simultaneously, available in 96-well breakaway or 384-well formats. Used by clinical diagnostic and reference laboratories for infectious disease testing to reduce error rate, improve turnaround times, and lower reagent waste.

2Simplicity Dx Extraction System
CategorySample Preparation / Nucleic Acid Extraction Instruments
Description

Automated nucleic acid extraction system that uses magnetic bead separation technology to process 1-32 samples simultaneously in 30 minutes with greater than 98% nucleic acid recovery consistency. Features UV sterilization, disposable tips, and touchscreen interface for clinical molecular diagnostic labs.

3Opti-Swab Liquid Amies Transport System
CategorySpecimen Collection and Transport
Description

Advanced specimen collection and transport solution using Liquid Amies medium that enables reliable collection and transport of viral and bacterial pathogens for downstream molecular testing applications.

4Nest Collection (Nylon Flocked Swabs)
CategorySpecimen Collection and Transport
Description

State-of-the-art nylon flocked nasopharyngeal and oropharyngeal specimen collection swabs pre-packaged with Inactivation Transport Medium (ITM) that inactivates viruses, prevents nucleic acid degradation, and supports room-temperature transport for downstream molecular testing.

5Simplicity Connect
CategoryLaboratory Information System / Workflow Software
Description

Cloud-based Laboratory Information System (LIS) with integrated CRM capabilities that automates workflows, provides analytics, and integrates with EHR systems, laboratory billing systems, and PCR instruments for infectious disease, COVID-19, and cancer genomics testing. Sold on a flexible annual subscription.

6Gastrointestinal Microbiota 18 Simplicity Panel™
CategoryMultiplex PCR Assay Panels
Description

Multiplex PCR assay for identification of nucleic acids from 18 organisms associated with gastrointestinal tract infections, including bacteria (Clostridium difficile, Campylobacter, E. coli, Salmonella, Shigella, Vibrio, Yersinia), viruses (Adenovirus, Norovirus, Rotavirus, Astrovirus), and parasites (Cryptosporidium, Giardia, Entamoeba). For research use only.

7HPV Simplicity Panel™
CategoryMultiplex PCR Assay Panels
Description

Multiplex PCR research panel designed to identify 14 high-risk HPV types, supporting research into HPV prevalence and its role in cancers. For research use only.

8PCR Reagents
CategoryLife Science Research Reagents
Description

Comprehensive range of proprietary specialty thermal DNA polymerases and PCR reagents for research use, including Taq polymerases and master mixes. Sold through the research.moleculardesigns.com e-commerce portal to research laboratories.

9qPCR / Real-time PCR / RT-PCR Reagents
CategoryLife Science Research Reagents
Description

Reagents for quantitative PCR, real-time PCR, and reverse transcription PCR applications, sold to research laboratories through the research.moleculardesigns.com e-commerce portal.

10Direct PCR and Genotyping
CategoryLife Science Research Reagents
Description

Extractionless PCR solutions enabling direct amplification from samples without prior DNA/RNA purification, used by research laboratories for genotyping and related molecular biology applications.

11Protein Research and Cell Biology
CategoryLife Science Research Reagents
Description

Products for protein research including transfection reagents (SusFexin, LipoFexin), protein ladders, and cell biology tools sold to research laboratories.

12DNA/RNA Purification
CategoryLife Science Research Reagents
Description

DNA and RNA purification kits including Column-Pure Plasmid Miniprep Kit and Classic Genomic DNA Isolation Kit, sold to research laboratories.

13DNA Ladders & SafeStain
CategoryLife Science Research Reagents
Description

DNA molecular weight markers including 1KB Plus DNA Ladder and 100 bp DNA Ladder, combined with SafeStain visualization solution for research laboratory use.

14Culture Media & Biochemicals
CategoryLife Science Research Reagents
Description

Culture media and biochemical reagents for laboratory research applications, sold through research.moleculardesigns.com.

15Plasmid DNA Prep Service
CategoryLife Science Services
Description

Contract plasmid DNA purification service offered to research laboratories.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

Molecular Designs completed the acquisition of Lamda Biotech in September 2024, expanding its product portfolio and market reach in molecular biology and genomics research products. The acquisition also expanded Molecular Designs' talent base in the molecular technology sector.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Meridian develops and manufactures molecular diagnostic reagents and kits for infectious disease testing, closely mirroring Molecular Designs' Simplicity Panels and life science PCR reagent portfolio.

TypeBroad incumbent
Description

Thermo Fisher's QuantStudio 5 Dx is one of Molecular Designs' primary supported instruments, and its broader Applied Biosystems portfolio of PCR instruments, reagents, and diagnostic assays is the dominant incumbent Molecular Designs must sell alongside and against.

TypeDirect peer
Description

Cepheid's GeneXpert system is a leading automated molecular diagnostics platform with broad infectious disease and oncology menus; it competes head-to-head with Simplicity Panels for clinical lab throughput and is part of Molecular Designs' referenced competitive set.

TypeDirect peer
Description

BD's MAX System is an open-architecture multiplex molecular platform explicitly listed as a Molecular Designs-compatible instrument; BD competes both as an instrument vendor and as a panel provider against Simplicity Panels.

TypeBroad incumbent
Description

Hologic's Panther system is a fully automated molecular diagnostics platform widely deployed in high-volume labs; while broader in scope, it competes for the same infectious disease testing budgets as Molecular Designs' clinical workflow.

TypeDirect peer
Description

BioFire (a bioMérieux subsidiary) sells the FilmArray multiplex PCR panel systems—one of Molecular Designs' explicitly supported instrument platforms and its most direct competitor in syndromic infectious disease PCR testing for clinical and reference labs.

TypeDirect peer
Description

QIAGEN provides sample-prep extraction systems, PCR/qPCR reagents, and molecular diagnostic assays targeting both clinical and life science research labs—directly comparable to Molecular Designs' Simplicity Dx extraction, Simplicity Panels, and Lamda-derived research reagents.

TypeDirect peer
Description

DiaSorin's Luminex division sells multiplex molecular testing platforms and reagents for infectious disease diagnostics, overlapping with Molecular Designs' syndromic PCR panel offering for clinical laboratories.

TypeDirect peer
Description

QuidelOrtho offers the Savanna multiplex molecular platform and a broad infectious disease diagnostics menu; it directly competes with Simplicity Panels in clinical and reference laboratory settings.

TypeEmerging player
Description

Rheonix is a smaller molecular diagnostics company focused on automated sample-to-answer PCR workflows; it overlaps with Molecular Designs' workflow-integration thesis at a similar scale and stage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Molecular Designs

Molecular Diagnostics / PCR-based Clinical Diagnosticsmoleculardesigns.com

Molecular Designs is a physician-founded molecular diagnostics company that sells pre-plated multiplex PCR panels, automated extraction systems, specimen collection kits, and a cloud LIS/CRM to clinical/reference laboratories, plus research-grade PCR reagents and consumables to academic and biopharma labs.

What Molecular Designs does

Molecular Designs is a physician-founded molecular diagnostics and life science research tools company headquartered in Birmingham, Alabama. The company operates two divisions: a clinical diagnostics business built around the Simplicity™ platform (pre-plated breakaway multiplex PCR panels, the Simplicity Dx automated magnetic bead extraction system, Nest nylon flocked collection swabs with Inactivation Transport Medium, Opti-Swab transport systems, and the Simplicity Connect cloud-based LIS/CRM) and a life science research products division acquired through Lamda Biotech in September 2024, which sells PCR reagents, qPCR/RT-PCR reagents, direct PCR genotyping kits, protein research tools, DNA/RNA purification kits, DNA ladders, SafeStain, culture media, and a plasmid DNA prep service via research.moleculardesigns.com.

The underlying technology combines proprietary PCR chemistry, magnetic bead-based nucleic acid extraction (>98% recovery consistency, 30-minute runs on 1-32 samples), and integrated cloud software that connects to EHR, billing, and PCR instruments from ThermoFisher QuantStudio 5 Dx, BioFire FilmArray, BD MAX, and Sensititre ARIS. Manufacturing occurs in a 7,000 sq. ft. ISO 7 clean room facility with six high-speed Tecan filler machines producing 1,500-5,000 PCR plates per day, all under ISO 13485:2016 and GMP quality systems. R&D includes 10 PhDs on staff and 21 patents.

Molecular Designs monetizes through one-time sales of clinical PCR panels, extraction instruments, and consumables; subscription/quote-based licensing of Simplicity Connect; and unit-priced e-commerce sales of life science research reagents. Clinical products are sold via direct enterprise sales, while research products are sold direct-to-customer online with academic and volume pricing programs. Customers include clinical and reference laboratories performing infectious disease testing and academic/biopharma research laboratories purchasing PCR reagents and consumables.

Molecular Designs firmographics

Firmographics
Name
Molecular Designs
Legal name
Molecular Designs, LLC
Website
https://moleculardesigns.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
Molecular Designs is a physician-founded molecular diagnostics company that sells pre-plated multiplex PCR panels, automated extraction systems, specimen collection kits, and a cloud LIS/CRM to clinical/reference laboratories, plus research-grade PCR reagents and consumables to academic and biopharma labs.
Ownership category
akta.pro rank

Molecular Designs industry classification

Industry
Product category
Molecular Diagnostics / PCR-based Clinical Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)
akta.pro primary industry
Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
akta.pro secondary industries
Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

Keywords

  • Molecular diagnostics
  • PCR products
  • Nucleic acid extraction
  • Multiplex PCR panels
  • Clinical diagnostics

Where Molecular Designs is headquartered

Location

Headquarters

HQ city
Birmingham
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Molecular Designs business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain

Revenue model

  1. PCR Products and Consumables: Molecular Designs generates revenue through the sale of PCR products including Simplicity Panels (pre-plated PCR assays), extraction systems, collection kits, and related consumables. The company operates both a clinical diagnostics division (moleculardesigns.com) and a life science research products division (research.moleculardesigns.com).
  2. Simplicity Connect LIS Software: Cloud-based laboratory information system offered with flexible licensing and pricing model that scales with customer needs. Includes portals for clinicians, technicians, and customer support.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual Research Products
Unit PricingMulti-year contractAcademic and Volume Pricing Programs
SubscriptionAnnualSimplicity Connect LIS

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Molecular Designs product offering

Product offering

Core offering

Molecular Designs develops, manufactures, and sells PCR-based molecular diagnostic products and life science research reagents under the Simplicity™ platform. Its clinical portfolio includes pre-plated multiplex PCR panels, an automated magnetic bead nucleic acid extraction system, specimen collection/transport products, and a cloud-based LIS/CRM. Through its Life Science Products division (acquired from Lamda Biotech in 2024), it also sells PCR reagents, qPCR reagents, DNA/RNA purification kits, and protein research consumables to research laboratories.

Product overview

Molecular Designs operates as a physician-founded molecular technology company offering a unified product portfolio centered on Simplicity™ branded clinical diagnostic solutions and a separate Life Science Products division. The clinical portfolio consists of Simplicity Panels (customizable multiplex PCR plates), Simplicity Dx Extraction System (automated magnetic bead-based nucleic acid extraction), Nest Collection (nylon flocked swabs with ITM), Opti-Swab Transport System, and Simplicity Connect (cloud-based LIS/CRM platform). The company also offers an IVD respiratory panel for COVID/Flu/RSV in development. Through the 2024 acquisition of Lamda Biotech, Molecular Designs expanded into Life Science Products for research laboratories, including PCR reagents, qPCR/RT-PCR reagents, Direct PCR genotyping kits, protein research tools, DNA/RNA purification products, DNA ladders, SafeStain, culture media, and plasmid DNA preparation services. All Simplicity clinical products are manufactured under GMP and ISO 13485:2016 quality standards for research use only (RUO), with IVD products in development.

Differentiator

Problem solved

Functional benefit

Products and services

  • Simplicity Panel™ Customizable multiplex PCR plates that identify multiple pathogens simultaneously, available in 96-well breakaway or 384-well formats. Used by clinical diagnostic and reference laboratories for infectious disease testing to reduce error rate, improve turnaround times, and lower reagent waste.
  • Simplicity Dx Extraction System Automated nucleic acid extraction system that uses magnetic bead separation technology to process 1-32 samples simultaneously in 30 minutes with greater than 98% nucleic acid recovery consistency. Features UV sterilization, disposable tips, and touchscreen interface for clinical molecular diagnostic labs.
  • Opti-Swab Liquid Amies Transport System Advanced specimen collection and transport solution using Liquid Amies medium that enables reliable collection and transport of viral and bacterial pathogens for downstream molecular testing applications.
  • Nest Collection (Nylon Flocked Swabs) State-of-the-art nylon flocked nasopharyngeal and oropharyngeal specimen collection swabs pre-packaged with Inactivation Transport Medium (ITM) that inactivates viruses, prevents nucleic acid degradation, and supports room-temperature transport for downstream molecular testing.
  • Simplicity Connect Cloud-based Laboratory Information System (LIS) with integrated CRM capabilities that automates workflows, provides analytics, and integrates with EHR systems, laboratory billing systems, and PCR instruments for infectious disease, COVID-19, and cancer genomics testing. Sold on a flexible annual subscription.
  • Gastrointestinal Microbiota 18 Simplicity Panel™ Multiplex PCR assay for identification of nucleic acids from 18 organisms associated with gastrointestinal tract infections, including bacteria (Clostridium difficile, Campylobacter, E. coli, Salmonella, Shigella, Vibrio, Yersinia), viruses (Adenovirus, Norovirus, Rotavirus, Astrovirus), and parasites (Cryptosporidium, Giardia, Entamoeba). For research use only.
  • HPV Simplicity Panel™ Multiplex PCR research panel designed to identify 14 high-risk HPV types, supporting research into HPV prevalence and its role in cancers. For research use only.
  • PCR Reagents Comprehensive range of proprietary specialty thermal DNA polymerases and PCR reagents for research use, including Taq polymerases and master mixes. Sold through the research.moleculardesigns.com e-commerce portal to research laboratories.
  • qPCR / Real-time PCR / RT-PCR Reagents Reagents for quantitative PCR, real-time PCR, and reverse transcription PCR applications, sold to research laboratories through the research.moleculardesigns.com e-commerce portal.
  • Direct PCR and Genotyping Extractionless PCR solutions enabling direct amplification from samples without prior DNA/RNA purification, used by research laboratories for genotyping and related molecular biology applications.
  • Protein Research and Cell Biology Products for protein research including transfection reagents (SusFexin, LipoFexin), protein ladders, and cell biology tools sold to research laboratories.
  • DNA/RNA Purification DNA and RNA purification kits including Column-Pure Plasmid Miniprep Kit and Classic Genomic DNA Isolation Kit, sold to research laboratories.
  • DNA Ladders & SafeStain DNA molecular weight markers including 1KB Plus DNA Ladder and 100 bp DNA Ladder, combined with SafeStain visualization solution for research laboratory use.
  • Culture Media & Biochemicals Culture media and biochemical reagents for laboratory research applications, sold through research.moleculardesigns.com.
  • Plasmid DNA Prep Service Contract plasmid DNA purification service offered to research laboratories.

Quantifiable outcome

  • 82% less prep time with streamlined workflows
  • +6 more outcomes

Companies that use Molecular Designs

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Molecular Designs technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Molecular Designs partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Lamda BiotechcoreStrategic or Co-development Partner · 1 September 2025Molecular Designs completed the acquisition of Lamda Biotech in September 2024, expanding its product portfolio and market reach in molecular biology and genomics research products. The acquisition also expanded Molecular Designs' talent base in the molecular technology sector.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Molecular Designs competitors and assessment

Company assessment

Direct peers

  • Meridian Bioscience: Meridian develops and manufactures molecular diagnostic reagents and kits for infectious disease testing, closely mirroring Molecular Designs' Simplicity Panels and life science PCR reagent portfolio.
  • Cepheid (Danaher): Cepheid's GeneXpert system is a leading automated molecular diagnostics platform with broad infectious disease and oncology menus; it competes head-to-head with Simplicity Panels for clinical lab throughput and is part of Molecular Designs' referenced competitive set.
  • Becton Dickinson (BD) – BD MAX System: BD's MAX System is an open-architecture multiplex molecular platform explicitly listed as a Molecular Designs-compatible instrument; BD competes both as an instrument vendor and as a panel provider against Simplicity Panels.
  • BioFire Diagnostics (bioMérieux): BioFire (a bioMérieux subsidiary) sells the FilmArray multiplex PCR panel systems—one of Molecular Designs' explicitly supported instrument platforms and its most direct competitor in syndromic infectious disease PCR testing for clinical and reference labs.
  • QIAGEN: QIAGEN provides sample-prep extraction systems, PCR/qPCR reagents, and molecular diagnostic assays targeting both clinical and life science research labs—directly comparable to Molecular Designs' Simplicity Dx extraction, Simplicity Panels, and Lamda-derived research reagents.
  • DiaSorin (Luminex): DiaSorin's Luminex division sells multiplex molecular testing platforms and reagents for infectious disease diagnostics, overlapping with Molecular Designs' syndromic PCR panel offering for clinical laboratories.
  • QuidelOrtho: QuidelOrtho offers the Savanna multiplex molecular platform and a broad infectious disease diagnostics menu; it directly competes with Simplicity Panels in clinical and reference laboratory settings.

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher's QuantStudio 5 Dx is one of Molecular Designs' primary supported instruments, and its broader Applied Biosystems portfolio of PCR instruments, reagents, and diagnostic assays is the dominant incumbent Molecular Designs must sell alongside and against.
  • Hologic: Hologic's Panther system is a fully automated molecular diagnostics platform widely deployed in high-volume labs; while broader in scope, it competes for the same infectious disease testing budgets as Molecular Designs' clinical workflow.

Emerging players

  • Rheonix: Rheonix is a smaller molecular diagnostics company focused on automated sample-to-answer PCR workflows; it overlaps with Molecular Designs' workflow-integration thesis at a similar scale and stage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights4 records

Customer concentration

Molecular Designs social profiles

Digital presence

Molecular Designs compliance and trust

Trust signal

Compliance2 records

Molecular Designs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Molecular Designs leadership team

Management profile

Number of profiles

Profiles8 records

Molecular Designs subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Molecular Designs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Molecular Designs M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Molecular Designs

What does Molecular Designs do?

Molecular Designs develops, manufactures, and sells PCR-based molecular diagnostic products and life science research reagents under the Simplicity™ platform. Its clinical portfolio includes pre-plated multiplex PCR panels, an automated magnetic bead nucleic acid extraction system, specimen collection/transport products, and a cloud-based LIS/CRM. Through its Life Science Products division (acquired from Lamda Biotech in 2024), it also sells PCR reagents, qPCR reagents, DNA/RNA purification kits, and protein research consumables to research laboratories.

Is Molecular Designs a public or private company?

Molecular Designs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Molecular Designs founded?

Molecular Designs was founded in 2019. It employs 51 to 100 people.

Where is Molecular Designs based?

Molecular Designs is headquartered in Birmingham, United States, in the North America region.

How does Molecular Designs make money?

Two revenue lines are on record. PCR Products and Consumables are the primary driver. The others are simplicity Connect LIS Software.

Who are Molecular Designs's main competitors?

Direct peers on record are Meridian Bioscience, Cepheid (Danaher), Becton Dickinson (BD) – BD MAX System, BioFire Diagnostics (bioMérieux), QIAGEN, DiaSorin (Luminex) and QuidelOrtho. Broad incumbents are Thermo Fisher Scientific and Hologic. Rheonix is listed as an emerging player.

Does Molecular Designs have an API?

No public API is recorded for Molecular Designs.

What industry is Molecular Designs in?

Molecular Designs's product category is Molecular Diagnostics / PCR-based Clinical Diagnostics. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizMolecular Designs Launches Multiplex PCR Panel to Accelerate High-Risk HPV ResearchMolecular Designs announced the launch of its HPV Simplicity Panel, a next-generation multiplex PCR-based Research Use Only panel designed to identify 14 high-risk HPV types including 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68. The panel delivers same-day results with high analytical accuracy and reproducibility, comes pre-plated in a 96-well format, and requires no master-mix preparation. The company states the panel was developed to help research labs generate reliable data faster while supporting clinical research into HPV-related disease development.PR NewswireMolecular Designs Simplifies High-Risk HPV Clinical Research with New Multiplex PCR PanelMolecular Designs announced the launch of its Human Papillomavirus (HPV) Simplicity Panel, a next-generation multiplex PCR-based Research Use Only panel designed to identify 14 high-risk HPV types. The panel delivers same-day results with high analytical accuracy and comes pre-plated in a 96-well format requiring no master-mix preparation. The product targets research laboratories studying HPV prevalence and disease development, supporting the company's commitment to simplifying molecular workflows in infectious disease identification.PR NewswireMolecular Designs Submits Simplicity™DX Respiratory Panel for FDA 510(k) ClearanceMolecular Designs submitted a 510(k) premarket notification to the FDA for its Simplicity™Dx Respiratory Panel, an in vitro diagnostic designed for simultaneous detection of SARS-CoV-2, Influenza A, Influenza B, and RSV using multiplex real-time RT-PCR technology. The panel features a breakaway format allowing labs to run only the tests needed per batch, reducing waste, managing inventory more efficiently, and lowering costs amid staffing constraints and unpredictable testing volumes. CEO Michael Clark called the submission an important milestone reflecting the company's commitment to providing clinically sound, practical tools for clinical labs.PR NewswireMolecular Designs Launches Urogenital Microbiota Panel to Detect Pathogens and Antibiotic ResistanceMolecular Designs launched its Urogenital Microbiota with ABX 53 Simplicity Panel, a multiplex PCR-based research-use panel for urogenital samples. It detects 28 urinary targets (20 bacterial, 7 fungal, 1 protozoan) and 25 antibiotic resistance markers, delivering same-day results. The panel aims to streamline workflows and support antimicrobial stewardship.HealthcaredealflowMolecular Designs Announces Acquisition of Lamda Biotech -Molecular Designs has announced the acquisition of Lamda Biotech, a specialized provider of research products for molecular biology and gene therapy. This transaction aims to enhance Molecular Designs' product portfolio and expand its reach into academic research and pharmaceutical market segments.PR NewswireMolecular Designs Announces Acquisition of Lamda BiotechMolecular Designs announced the acquisition of Lamda Biotech on September 25, 2024. The transaction aims to enhance Molecular Designs' product portfolio and expand its reach into academic research and pharmaceutical markets by leveraging Lamda's specialized PCR products and expertise. This move solidifies Molecular Designs' position as a key player in the molecular technology market.PR NewswireMolecular Designs releases their new Direct-PCR Covid/Flu/RSV Simplicity Panel™ productMolecular Designs, a developer and manufacturer of molecular infectious disease assays, announced the release of its new Direct-PCR Covid/Flu/RSV Simplicity Panel™ on October 10, 2023. The panel is a multiplex RT-PCR assay for the qualitative detection of respiratory viral nucleic acids using an extractionless sample preparation process that reduces cost, time, and equipment compared to traditional methods. The assays are manufactured to GMP and ISO 13485:2016 quality standards and are compatible with most PCR platforms.PR NewswireMolecular Designs Receives ISO 13485:2016 CertificationMolecular Designs, LLC announced the successful completion of an ISO 13485:2016 inspection and certification of its Quality Management System, demonstrating the company's commitment to designing, developing, producing, and delivering PCR-based molecular multiplex pathogen assays that meet strict international quality standards. ISO 13485:2016 is an internationally recognized quality standard that defines requirements for medical device manufacturers' quality systems. The CEO stated the certification supports the company's goal of bringing additional assays currently in development to market.PR NewswireMolecular Designs Develops New COVID-19 UK Variant PCR Test for Assurance Scientific LaboratoriesMolecular Designs has developed a PCR test capable of differentiating the UK variant of COVID-19, with Assurance Scientific Laboratories currently validating the test for clinical use under its existing FDA Emergency Use Authorization. The test targets four signature mutations in the UK variant and could be available by the end of February 2021, offering a faster and less expensive alternative to genomic sequencing. Assurance is also working to identify South African and Brazilian variants.